Skip to main content
NCBI home page
Biophysical Journal logoLink to Biophysical Journal
. 1994 Dec;67(6):2376–2386. doi: 10.1016/S0006-3495(94)80724-6

Interaction of the NMDA receptor noncompetitive antagonist MK-801 with model and native membranes.

J Moring 1, L A Niego 1, L M Ganley 1, M W Trumbore 1, L G Herbette 1
PMCID: PMC1225622  PMID: 7696477

Abstract

MK-801, a noncompetitive antagonist of the NMDA (N-methyl-D-aspartate) receptor, has protective effects against excitotoxicity and ethanol withdrawal seizures. We have determined membrane/buffer partition coefficients (Kp[mem]) of MK-801 and its rates of association with and dissociation from membranes. Kp[mem] (+/- SD) = 1137 (+/- 320) in DOPC membranes and 485 (+/- 99) in synaptoneurosomal (SNM) lipid membranes from rat cerebral cortex (unilamellar vesicles). In multilamellar vesicles, Kp[mem] was higher: 3374 (+/- 253) in DOPC and 6879 (+/- 947) in SNM. In cholesterol/DOPC membranes, Kp[mem] decreased as the cholesterol content increased. MK-801 associated with and dissociated from membranes rapidly. Addition of ethanol to SNM did not affect Kp[mem]. MK-801 decreased the cooperative unit size of DMPC membranes. The decrease was smaller than that caused by 1,4-dihydropyridine drugs, indicating a weaker interaction with the hydrocarbon core. Small angle x-ray diffraction, with multilayer autocorrelation difference function modeling, indicated that MK-801 in a cholesterol/DOPC membrane (mole ratio = 0.6) causes a perturbation at approximately 16.0 A from the bilayer center. In bilayers of cholesterol/DOPC = 0.15 (mole ratio) or pure DOPC, the perturbation caused by MK-801 was more complex. The physical chemical interactions of MK-801 with membranes in vitro are consistent with a fast onset and short duration of action in vivo.

Full text

PDF
2376

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bangham A. D., Standish M. M., Watkins J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965 Aug;13(1):238–252. doi: 10.1016/s0022-2836(65)80093-6. [DOI] [PubMed] [Google Scholar]
  2. Chester D. W., Herbette L. G., Mason R. P., Joslyn A. F., Triggle D. J., Koppel D. E. Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers. Biophys J. 1987 Dec;52(6):1021–1030. doi: 10.1016/S0006-3495(87)83295-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chester D. W., Tourtellotte M. E., Melchior D. L., Romano A. H. The influence of saturated fatty acid modulation of bilayer physical state on cellular and membrane structure and function. Biochim Biophys Acta. 1986 Aug 21;860(2):383–398. doi: 10.1016/0005-2736(86)90535-3. [DOI] [PubMed] [Google Scholar]
  4. Clark N. A., Rothschild K. J., Luippold D. A., Simon B. A. Surface-induced lamellar orientation of multilayer membrane arrays. Theoretical analysis and a new method with application to purple membrane fragments. Biophys J. 1980 Jul;31(1):65–96. doi: 10.1016/S0006-3495(80)85041-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cullis P. R., Bally M. B., Madden T. D., Mayer L. D., Hope M. J. pH gradients and membrane transport in liposomal systems. Trends Biotechnol. 1991 Aug;9(8):268–272. doi: 10.1016/0167-7799(91)90088-y. [DOI] [PubMed] [Google Scholar]
  6. De Montis M. G., Devoto P., Meloni D., Gambarana C., Giorgi G., Tagliamonte A. NMDA receptor inhibition prevents tolerance to cocaine. Pharmacol Biochem Behav. 1992 May;42(1):179–182. doi: 10.1016/0091-3057(92)90463-p. [DOI] [PubMed] [Google Scholar]
  7. Foster A. C., Wong E. H. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Br J Pharmacol. 1987 Jun;91(2):403–409. doi: 10.1111/j.1476-5381.1987.tb10295.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gill R., Foster A. C., Woodruff G. N. MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period. Neuroscience. 1988 Jun;25(3):847–855. doi: 10.1016/0306-4522(88)90040-1. [DOI] [PubMed] [Google Scholar]
  9. Grant K. A., Valverius P., Hudspith M., Tabakoff B. Ethanol withdrawal seizures and the NMDA receptor complex. Eur J Pharmacol. 1990 Feb 13;176(3):289–296. doi: 10.1016/0014-2999(90)90022-x. [DOI] [PubMed] [Google Scholar]
  10. Heider J. G., Boyett R. L. The picomole determination of free and total cholesterol in cells in culture. J Lipid Res. 1978 May;19(4):514–518. [PubMed] [Google Scholar]
  11. Herbette L. G., Chester D. W., Rhodes D. G. Structural analysis of drug molecules in biological membranes. Biophys J. 1986 Jan;49(1):91–94. doi: 10.1016/S0006-3495(86)83605-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Herbette L. G., Gaviraghi G., Tulenko T., Mason R. P. Molecular interaction between lacidipine and biological membranes. J Hypertens Suppl. 1993 Mar;11(1):S13–S19. doi: 10.1097/00004872-199303001-00003. [DOI] [PubMed] [Google Scholar]
  13. Herbette L. G., Vant Erve Y. M., Rhodes D. G. Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors. J Mol Cell Cardiol. 1989 Feb;21(2):187–201. doi: 10.1016/0022-2828(89)90861-4. [DOI] [PubMed] [Google Scholar]
  14. Herbette L., Napolitano C. A., Messineo F. C., Katz A. M. Interaction of amphiphilic molecules with biological membranes. A model for nonspecific and specific drug effects with membranes. Adv Myocardiol. 1985;5:333–346. [PubMed] [Google Scholar]
  15. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol. 1977 Apr;69(4):497–515. doi: 10.1085/jgp.69.4.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hoffman P. L., Rabe C. S., Grant K. A., Valverius P., Hudspith M., Tabakoff B. Ethanol and the NMDA receptor. Alcohol. 1990 May-Jun;7(3):229–231. doi: 10.1016/0741-8329(90)90010-a. [DOI] [PubMed] [Google Scholar]
  17. Hollingsworth E. B., McNeal E. T., Burton J. L., Williams R. J., Daly J. W., Creveling C. R. Biochemical characterization of a filtered synaptoneurosome preparation from guinea pig cerebral cortex: cyclic adenosine 3':5'-monophosphate-generating systems, receptors, and enzymes. J Neurosci. 1985 Aug;5(8):2240–2253. doi: 10.1523/JNEUROSCI.05-08-02240.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Khanna J. M., Kalant H., Shah G., Chau A. Effect of (+)MK-801 and ketamine on rapid tolerance to ethanol. Brain Res Bull. 1992 Feb;28(2):311–314. doi: 10.1016/0361-9230(92)90193-2. [DOI] [PubMed] [Google Scholar]
  19. King G. I., Jacobs R. E., White S. H. Hexane dissolved in dioleoyllecithin bilayers has a partial molar volume of approximately zero. Biochemistry. 1985 Aug 13;24(17):4637–4645. doi: 10.1021/bi00338a024. [DOI] [PubMed] [Google Scholar]
  20. Kloog Y., Nadler V., Sokolovsky M. Mode of binding of [3H]dibenzocycloalkenimine (MK-801) to the N-methyl-D-aspartate (NMDA) receptor and its therapeutic implication. FEBS Lett. 1988 Mar 28;230(1-2):167–170. doi: 10.1016/0014-5793(88)80664-1. [DOI] [PubMed] [Google Scholar]
  21. Koyuncuoğlu H., Dizdar Y., Aricioğlu F., Sayin U. Effects of MK 801 on morphine physical dependence: attenuation and intensification. Pharmacol Biochem Behav. 1992 Oct;43(2):487–490. doi: 10.1016/0091-3057(92)90181-e. [DOI] [PubMed] [Google Scholar]
  22. Kozikowski A. P., Tueckmantel W., Maloneyhuss K. The discovery of new chemical modulators of the N-methyl-D-aspartate receptor. Ann N Y Acad Sci. 1989;568:159–165. doi: 10.1111/j.1749-6632.1989.tb12503.x. [DOI] [PubMed] [Google Scholar]
  23. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  24. Leeson P. D., Carling R. W., James K., Smith J. D., Moore K. W., Wong E. H., Baker R. Role of hydrogen bonding in ligand interaction with the N-methyl-D-aspartate receptor ion channel. J Med Chem. 1990 May;33(5):1296–1305. doi: 10.1021/jm00167a005. [DOI] [PubMed] [Google Scholar]
  25. Lovinger D. M., White G., Weight F. F. NMDA receptor-mediated synaptic excitation selectively inhibited by ethanol in hippocampal slice from adult rat. J Neurosci. 1990 Apr;10(4):1372–1379. doi: 10.1523/JNEUROSCI.10-04-01372.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Monaghan D. T., Bridges R. J., Cotman C. W. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol. 1989;29:365–402. doi: 10.1146/annurev.pa.29.040189.002053. [DOI] [PubMed] [Google Scholar]
  27. Reynolds I. J., Miller R. J. Multiple sites for the regulation of the N-methyl-D-aspartate receptor. Mol Pharmacol. 1988 Jun;33(6):581–584. [PubMed] [Google Scholar]
  28. Rhodes D. G., Newton R., Butler R., Herbette L. Equilibrium and kinetic studies of the interactions of salmeterol with membrane bilayers. Mol Pharmacol. 1992 Oct;42(4):596–602. [PubMed] [Google Scholar]
  29. Rhodes D. G., Sarmiento J. G., Herbette L. G. Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site. Mol Pharmacol. 1985 Jun;27(6):612–623. [PubMed] [Google Scholar]
  30. Rupniak N. M., Boyce S., Tye S., Cook G., Iversen S. D. Anxiolytic-like and antinociceptive effects of MK-801 accompanied by sedation and ataxia in primates. Pharmacol Biochem Behav. 1993 Jan;44(1):153–156. doi: 10.1016/0091-3057(93)90293-3. [DOI] [PubMed] [Google Scholar]
  31. Sakurada K., Masu M., Nakanishi S. Alteration of Ca2+ permeability and sensitivity to Mg2+ and channel blockers by a single amino acid substitution in the N-methyl-D-aspartate receptor. J Biol Chem. 1993 Jan 5;268(1):410–415. [PubMed] [Google Scholar]
  32. Schwarcz R., Meldrum B. Excitatory aminoacid antagonists provide a therapeutic approach to neurological disorders. Lancet. 1985 Jul 20;2(8447):140–143. doi: 10.1016/s0140-6736(85)90238-7. [DOI] [PubMed] [Google Scholar]
  33. Steele J. E., Robinson T. N., Cross A. J., Bowen D. M., Green A. R. A comparison of [3H]MK-801 and N-[1-(2-thienyl)cyclohexyl]-3,4-[3H]piperidine binding to the N-methyl-D-aspartate receptor complex in human brain. J Neurochem. 1991 Apr;56(4):1248–1254. doi: 10.1111/j.1471-4159.1991.tb11418.x. [DOI] [PubMed] [Google Scholar]
  34. Sun G. Y., Lin T. N. Time course for labeling of brain membrane phosphoinositides and other phospholipids after intracerebral injection of [32P]-ATP. Evaluation by an improved HPTLC procedure. Life Sci. 1989;44(10):689–696. doi: 10.1016/0024-3205(89)90475-x. [DOI] [PubMed] [Google Scholar]
  35. Tabatabaei A., Perry T. L., Hansen S., Krieger C. Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice. Neurosci Lett. 1992 Jul 20;141(2):192–194. doi: 10.1016/0304-3940(92)90892-b. [DOI] [PubMed] [Google Scholar]
  36. Tasker R. C., Coyle J. T., Vornov J. J. The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801. J Neurosci. 1992 Nov;12(11):4298–4308. doi: 10.1523/JNEUROSCI.12-11-04298.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Trujillo K. A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 1991 Jan 4;251(4989):85–87. doi: 10.1126/science.1824728. [DOI] [PubMed] [Google Scholar]
  38. Trumbore M., Chester D. W., Moring J., Rhodes D., Herbette L. G. Structure and location of amiodarone in a membrane bilayer as determined by molecular mechanics and quantitative x-ray diffraction. Biophys J. 1988 Sep;54(3):535–543. doi: 10.1016/S0006-3495(88)82986-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Vezzani A., Serafini R., Stasi M. A., Caccia S., Conti I., Tridico R. V., Samanin R. Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. J Pharmacol Exp Ther. 1989 Apr;249(1):278–283. [PubMed] [Google Scholar]
  40. Wong E. H., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N., Iversen L. L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7104–7108. doi: 10.1073/pnas.83.18.7104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wu P. H., Mihic S. J., Liu J. F., Lê A. D., Kalant H. Blockade of chronic tolerance to ethanol by the NMDA antagonist, (+)-MK-801. Eur J Pharmacol. 1993 Feb 9;231(2):157–164. doi: 10.1016/0014-2999(93)90444-m. [DOI] [PubMed] [Google Scholar]
  42. Young H. S., Skita V., Mason R. P., Herbette L. G. Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by a nonspecific site interaction mechanism. Biophys J. 1992 May;61(5):1244–1255. doi: 10.1016/S0006-3495(92)81933-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Zuddas A., Vaglini F., Fornai F., Fascetti F., Saginario A., Corsini G. U. Pharmacologic modulation of MPTP toxicity: MK 801 in prevention of dopaminergic cell death in monkeys and mice. Ann N Y Acad Sci. 1992 May 11;648:268–271. doi: 10.1111/j.1749-6632.1992.tb24553.x. [DOI] [PubMed] [Google Scholar]
  44. el-Asrar A. M., Morse P. H., Maimone D., Torczynski E., Reder A. T. MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate. Invest Ophthalmol Vis Sci. 1992 Nov;33(12):3463–3468. [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES